Clinical Trial Update: Glasdegib (PF-04449913) With Temozolomide Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update involving glasdegib with temozolomide for newly diagnosed glioblastoma (Phase 1/Phase 2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Glasdegib (glasdegib)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED